Top Glove Corp - Still Not Out of the Woods; Stay SELL

Date: 
2022-09-28
Firm: 
RHB-OSK
Stock: 
Price Target: 
0.49
Price Call: 
SELL
Last Price: 
0.91
Upside/Downside: 
-0.42 (46.15%)
  • Maintain SELL, new TP of MYR0.49 from MYR0.60, 20% downside. Post announcement of Top Glove’s latest quarterly results, its share price has declined to close to our previous TP of MYR0.60. We believe there could be further downside risk on the stock due to the lack of near-term catalysts. As such, we pare down our TP again, and lift our cost of equity assumption to 13% from 12%, while keeping other assumptions unchanged.
  • ASP back to pre-pandemic levels. As per our channel checks, local glovemakers are not likely to engage in a price war with their China counterparts, even though the latter is selling gloves at c.USD19 per 1,000 pieces (local ASP: USD24 per 1,000 pieces as of August, marking a difference of 21%). Note that gloves from China are still subjected to a 7.5% import tariff from the US – although this is expected to expire in end- November. There could be a potential downside risk of ASP erosion, if the United States Trade Representative abolishes the tariff on Chinese glove imports.
  • Demand unlikely to pick up yet. The inventory levels of some prominent glove distributors were still high as of June (higher than pre-pandemic levels by c.30-50%) despite seeing some signs of depletion recently. We think that the glove distributors’ inventory drawdown may take at least a year before easing to pre-pandemic levels – taking into consideration normalised demand and the lofty inventory levels of the glove distributors (inventory on hand could still last for another six months). As such, we expect global demand growth to remain sluggish, at 4% and 6% for 2023 and 2024.
  • Supply. Industry supply remains elevated – estimated at 429bn pieces by end-2022, with the Malaysian top four producers accounting for 47% of global market share in terms of effective production capacity (or 201.7bn pieces). This also builds in our assumption of a delay in capacity commissioning towards 2H23, given the current low industry utilisation rate of 50-60%. Encouragingly, the top four players’ inventories had depleted by 9% (on average) in the recent Jun/Aug 2022 quarter. However, the percentage of finished goods vs total inventories remains elevated, as per data from the companies’ annual reports.
  • Earnings revision and valuation. We maintain our earnings estimates, but raise our assumption on cost of equity to 13%, from 12%. Top Glove’s share price has declined by 8% as at 23 Sep, following its disappointing latest quarterly results.
  • Key upside risks are: An increase in glove ASPs, faster-than-expected capacity expansion, higher-than-expected utilisation rates, and cheaper- than-estimated raw material prices.

Source: RHB Research - 28 Sep 2022

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment